Per Albertsson

9.7k total citations · 2 hit papers
174 papers, 6.9k citations indexed

About

Per Albertsson is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Per Albertsson has authored 174 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Cardiology and Cardiovascular Medicine, 65 papers in Radiology, Nuclear Medicine and Imaging and 58 papers in Surgery. Recurrent topics in Per Albertsson's work include Acute Myocardial Infarction Research (48 papers), Coronary Interventions and Diagnostics (40 papers) and Cardiac Imaging and Diagnostics (34 papers). Per Albertsson is often cited by papers focused on Acute Myocardial Infarction Research (48 papers), Coronary Interventions and Diagnostics (40 papers) and Cardiac Imaging and Diagnostics (34 papers). Per Albertsson collaborates with scholars based in Sweden, Denmark and United States. Per Albertsson's co-authors include Gregg W. Stone, Sigmund Silber, Antonio Colombo, Philip Urban, Paolo G. Camici, Jean Marco, William Wijns, Francisco Fernández‐Avilés, Erik Jørgensen and Elmir Ömerovic and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Per Albertsson

170 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Guidelines for Percutaneous Coronary Interventions

2005 1.1k citations Sigmund Silber, Per Albertsson et al. European Heart Journal profile →
Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial

2015 305 citations Per Albertsson et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Per Albertsson Sweden	43	3.7k	2.9k	2.6k	939	685	174	6.9k
Julio Núñez Spain	45	6.5k 1.7×	1.9k 0.7×	1.9k 0.7×	1.4k 1.5×	917 1.3×	560	10.0k
Juan Sanchís Spain	43	5.2k 1.4×	1.7k 0.6×	1.7k 0.7×	894 1.0×	769 1.1×	414	7.3k
Evangelos Giannitsis Germany	45	7.5k 2.0×	2.1k 0.7×	3.6k 1.4×	549 0.6×	266 0.4×	278	9.3k
Andrew T. Yan Canada	45	5.4k 1.5×	1.8k 0.6×	2.1k 0.8×	606 0.6×	361 0.5×	298	7.4k
David Brown United States	40	3.6k 1.0×	3.6k 1.2×	1.0k 0.4×	672 0.7×	248 0.4×	192	7.3k
Konstantinos Toutouzas Greece	33	2.4k 0.6×	1.8k 0.6×	1.2k 0.5×	1.1k 1.2×	264 0.4×	257	4.6k
Fabrizio D’Ascenzo Italy	43	4.8k 1.3×	3.1k 1.0×	1.4k 0.5×	1.2k 1.3×	303 0.4×	285	6.9k
George W. Vetrovec United States	51	4.8k 1.3×	5.0k 1.7×	2.6k 1.0×	1.6k 1.7×	148 0.2×	221	9.3k
Azfar Zaman United Kingdom	37	3.2k 0.8×	1.9k 0.6×	1.3k 0.5×	1.2k 1.2×	151 0.2×	198	5.9k
Steven R. Bailey United States	30	5.2k 1.4×	4.9k 1.7×	2.0k 0.8×	1.5k 1.6×	150 0.2×	134	8.3k

Countries citing papers authored by Per Albertsson

Since Specialization

Citations

This map shows the geographic impact of Per Albertsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Albertsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Albertsson more than expected).

Fields of papers citing papers by Per Albertsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Albertsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Albertsson. The network helps show where Per Albertsson may publish in the future.

Co-authorship network of co-authors of Per Albertsson

This figure shows the co-authorship network connecting the top 25 collaborators of Per Albertsson. A scholar is included among the top collaborators of Per Albertsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Albertsson. Per Albertsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Staf, Christian, et al.. (2022). Complications after advanced ovarian cancer surgery—A population‐based cohort study. Acta Obstetricia Et Gynecologica Scandinavica. 101(7). 747–757. 5 indexed citations

Fohlin, Helena, Per Albertsson, L-G Arnesson, et al.. (2021). Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up. The Breast. 59. 294–300. 22 indexed citations

Völz, Sebastian, Pétur Pétursson, Jacob Odenstedt, et al.. (2020). Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry. Journal of the American Heart Association. 9(14). e015990–e015990. 24 indexed citations

Lindegren, Sture, Per Albertsson, Tom Bäck, et al.. (2020). Realizing Clinical Trials with Astatine-211: The Chemistry Infrastructure. Cancer Biotherapy and Radiopharmaceuticals. 35(6). 425–436. 69 indexed citations

Haraldsson, Inger, Sara Svedlund, Björn Redfors, et al.. (2019). PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve. SHILAP Revista de lepidopterología. 1 indexed citations

Haraldsson, Inger, Li-Ming Gan, Sara Svedlund, et al.. (2019). <p>PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve</p>. Vascular Health and Risk Management. Volume 15. 375–384. 6 indexed citations

Varenhorst, Christoph, Saga Johansson, Pål Hasvold, et al.. (2016). Abstract 13206: Culprit and Non-Culprit Recurrent Ischemic Events in Post-Myocardial Infarction Patients: Data From SWEDEHEART. Circulation. 134(suppl_1).

Dworeck, Christian, Inger Haraldsson, Dan Ioanes, et al.. (2016). TCT-477 Long-term risk of stent thrombosis and restenosis after treatment with drug-eluting stents: A report from SCAAR. Journal of the American College of Cardiology. 68(18). B191–B192. 1 indexed citations

Redfors, Björn, Truls Råmunddal, Oskar Angerås, et al.. (2015). Angiographic findings and survival in patients undergoing coronary angiography due to sudden cardiac arrest in Western Sweden. Resuscitation. 90. 13–20. 22 indexed citations

10.

Aneheim, Emma, et al.. (2015). Shelf-Life of ɛ-Lysyl-3-(Trimethylstannyl)Benzamide Immunoconjugates, Precursors for ²¹¹ At Labeling of Antibodies. Cancer Biotherapy and Radiopharmaceuticals. 30(1). 41–45. 6 indexed citations

11.

Redfors, Björn, Oskar Angerås, Truls Råmunddal, et al.. (2015). Mortality in takotsubo syndrome is similar to mortality in myocardial infarction — A report from the SWEDEHEART11Swedish web system for enhancement of evidence-based care in heart disease evaluated according to recommended therapies. registry. International Journal of Cardiology. 185. 282–289. 227 indexed citations

12.

Angerås, Oskar, Per Albertsson, Truls Råmunddal, et al.. (2014). Impact of left main stenosis on one-year mortality in patients undergoing coronary angiography. European Heart Journal. 35. 150–150. 1 indexed citations

13.

Frost, Sofia H.L., Tom Bäck, Nicolas Chouin, et al.. (2012). Comparison of ²¹¹ At-PRIT and ²¹¹ At-RIT of Ovarian Microtumors in a Nude Mouse Model. Cancer Biotherapy and Radiopharmaceuticals. 28(2). 108–114. 18 indexed citations

14.

Angerås, Oskar, Per Albertsson, Kristjan Karason, et al.. (2012). Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. European Heart Journal. 34(5). 345–353. 217 indexed citations

15.

Halkin, Amir, Gregg W. Stone, Cindy L. Grines, et al.. (2006). Prognostic Implications of Creatine Kinase Elevation After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction. Journal of the American College of Cardiology. 47(5). 951–961. 57 indexed citations

16.

Silber, Sigmund, Per Albertsson, Francisco Fernández‐Avilés, et al.. (2005). Guidelines for Percutaneous Coronary Interventions. European Heart Journal. 26(8). 804–847. 1134 indexed citations breakdown →

17.

Kiemeneij, Ferdinand, Patrick W. Serruys, Carlos Macaya, et al.. (2001). Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. Journal of the American College of Cardiology. 37(6). 1598–1603. 153 indexed citations

18.

Kim, Myoung Hee, Richard P. Kitson, Per Albertsson, et al.. (2000). Secreted and Membrane-Associated Matrix Metalloproteinases of IL-2-Activated NK Cells and Their Inhibitors. The Journal of Immunology. 164(11). 5883–5889. 58 indexed citations

19.

Herlitz, Johan, Per Albertsson, Maria Haglid, et al.. (1996). The Cost-Benefit Balance of Coronary Artery Bypass Grafting: Need for Hospitalization During the Two Years Before and the Two Years After. The Thoracic and Cardiovascular Surgeon. 44(5). 239–244. 1 indexed citations

20.

Wiklund, Ingela, et al.. (1995). Relationship between quality of life and exercise test findings after coronary artery bypass surgery. International Journal of Cardiology. 51(3). 221–232. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact